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Acronyms 
ABS   Access and Benefit-Sharing 
ARIPO   African Regional Intellectual Property Organization (Anglophone)              
BIH   Botswana Innovation Hub  
CBD    Convention on Biological Diversity              
CAN  Competent National Authority 
EARO  Ethiopia Agricultural Research Organization  
EC    European Commission              
EEZ  exclusive economic zone  
EPO     European Patent Office              
EU     European Union              
FDI    Foreign Direct Investment              
FTA   Free Trade Agreement              
GIGRG  Inter-institutional Group on the Management of GR 
GR  Genetic resources 
HPFI   Health and Performance Food International BV – a Dutch Company 
ICT   Information Communication Technology 
IP   Intellectual Property              
IP Office – an office in an institution charged with managing IP 
IPRs    Intellectual Property Rights              
ITPGRFA International Treaty on Plant Genetic Resources for Food and Agriculture 
JV    Joint Venture              
MAT  Material Transfer Agreement 
MINEPDED  Ministry of Environment, Nature protection and Sustainable Development  
MTA  Mutually Agreed Terms 
MoU  Memorandum of Understanding 
NARO  National Agricultural Research Organisation (Uganda)  
NaSARRI  National Semi Arid Resources Research Institute  
NBL   Nile Breweries Limited   
NDA  Non-Disclosure Agreement/Confidentiality Agreement – an agreement to keep 
information confidential 
OAPI   Organisation Africaine de la Propriété Intellectuelle (Francophone)             
PCT   Patent Cooperation Treaty              
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PIC  Prior Informed Consent 
R&D  Research & Development              
RTA   Regional Trade Agreement              
S&CI   Soil and Crop Improvements Company 
SME   Small and Medium Enterprise              
SMTA  Standard Material Transfer Agreement 
TK  Traditional Knowledge 
TRIPS  Agreement on Trade Related Aspects of Intellectual Property              
UN  United Nations 
UNCS  Uganda National Council for Science  
UPIVC  university patent innovation value chain  
WIPO   World Intellectual Property Organization  
WTO    World Trade Organization 
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2. Definitions 
Access and benefit-sharing – fair and equitable sharing of benefits arising from use of genetic 
resources 
Bioprospecting – is the search for biological resources with actual or potential value for 
development into potential commercial applications 
Biotechnology - means any technological application that uses biological systems, living 
organisms, or derivatives thereof, to make or modify products or processes for specific 
use 
Contracting party – a party to a treaty that has agreed to be bound by the treaty 
Genetic resource – genetic material or plants or animals with actual or potential value 
(monetary or non-monetary) 
Licence – an instrument of complete or partial transfer of ownership of intellectual property 
from one party to another  
Material Transfer Agreement (MTA) – an instrument used to seal a relationship between the 
source (owners) of genetic material and the user of genetic material.  It is a form of 
contract that details what materials are in question, how they are to be passed on to the 
user, the benefits that should accrue to the owners, if money is involved – the mode of 
payment, if non-monetary benefits are involved – the form that such benefits should 
take, and so on. 
Mutually agreed terms (MAT) – terms of an agreement that have been understood and agreed 
upon by all parties in the negotiations. 
IP  intellectual property.  Refers to intangible property that results from creations of the 
mind, such as inventions; literary and artistic works; designs; and symbols, names and 
images used in commerce.  IP is protected in law by patents, utility models, copyright, 
trademarks, industrial designs, trade secrets, geographical indications amongst others.  
This protection is for a specified period of time to allow the inventors/creators earn 
recognition or financial benefit from what they invent or create 
Prior and informed Consent – or free prior and informed consent – it’s a process – 
o Prior – being given the opportunity to collaborate with and provide consent or 
objections to a project or development before it takes place with enough time to 
consider the information available and likely consequences 
o Informed- being given all information needed to decide whether or not to 
provide or withhold consent to a project or development. Information must be 
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current, in a language that can be understood, independent, and objective.  
Access to technical assistance must be available 
o Consent – giving permission to a particular project or agreement.  A community 
can provide or withhold consent. 
o Researcher – a person interested in exploring the potential applications of a 
genetic resource.  He ought to seek prior informed consent of the community to 
carry out commercial or non-commercial research about the properties and 
potential applications of a given genetic resource. 
Technology is science or knowledge put into practical use to solve problems or invent 
useful tools.  This knowledge includes methods, systems, and devices which are 
the result of scientific knowledge being used for practical purposes.  It also 
describes machinery and equipment developed from the application of scientific 
knowledge  
Traditional knowledge shall refer to any knowledge originating from a local or traditional 
community that is the result of intellectual activity and insight in a traditional 
context, including know-how, skills, innovations, practices and learning, where the 
knowledge is embodied in the traditional lifestyle of a community, or contained in 
the codified knowledge systems passed on from one generation to another.  The 
term shall not be limited to a specific technical field, and may include agricultural, 
environmental or medical knowledge, and knowledge associated with genetic 
resources.  
“University patent innovation value chain” means the whole process from scientific and 
technological innovation knowledge to patent value realization, including three stages: 
knowledge innovation, applied research and patent commercialization, and a dynamic 
feedback channel. 
 
3. Interpretation of terms 
“Access” means the opportunity to use genetic resources, data from research findings or new 
technology 
“Assignment” means the transfer of ownership of Intellectual Property Rights between the 
seller (Assignor) and the buyer (Assignee).  Where IP is jointly owned, all partners 
constitute the ‘assignor’ 
“Background Intellectual property” means all IP rights licensed to or owned by project 
partners at the beginning of the project and may include computer algorithms, 
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software codes, drawings, notebooks, data and photographs.  Use of such background 
IP in a joint project must be clearly agreed upon and also the ownership of new 
discoveries, improvements, and IP where background IP was used. 
“Benefit-sharing” means the sharing in a fair and equitable manner the research data from a 
project or the proceeds of commercialization of IP or technology resulting from a 
research project such as fees for assignment, licensing , joint venture or franchising.. 
“exclusive licence” means a licence contract that confers on the licensee and, where it is 
established expressly in it, on the persons authorised by the licensee, the right to 
exploit the licensed industrial property right to the exclusion of all other persons, 
including the rights owner;  
“Foreground IP”. means Intellectual Property that is, or has been created, exemplified or 
developed (whether in whole or in part) from the Research.  In a collaborative 
environment, this would be the IP that results from the collaborative project. 
“industrial property rights” mean rights under patents, certificates of utility models and 
technovation and registration of industrial designs issued under a relevant law; 
“Innovation’ means a process through which intangible products, services and or processes  
are produced from knowledge or results of research  thorough creation, diffusion and 
transformation of ideas..  Such products, services or processes usually represent a new 
addition or improvement to what already exists in. 
“Intellectual property (IP)” means an expression used for any intangible asset that does not 
exist in the physical.  The intangible nature of the design of a water bottle or the 
contents of a song on a CD easily makes them amenable to imitation.  Because of the 
great monetary value that these intangible goods have the law allows only those who 
actually own this intellectual property (IP) to use it.  Intellectual Property therefore 
refers to the protection of creations of the mind, inventions, literary and artistic 
works, computer programmes, data, symbols, brand names, images, and designs 
which have both a moral and a commercial value.  IP law typically grants the author 
of an intellectual creation exclusive rights for exploiting and benefiting from their 
creation. 
IP strategy is a plan by a business entity to acquire and use IP relevant to its business model.  
For example, money transfer technology is ideal for a telecommunications 
organisation .  It adds value to the general business of such an organisation .  The 
acquisition of various designs of cars adds value to a car manufacturer.  Further, the 
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development of drought resistant varieties of crops adds value to a seeds organisation  
or a biotechnology organisation .   
“invention” means a new and useful art whether producing a physical effect or not, process, 
machine, manufacture or composition of matter which is not obvious, or a new and 
useful improvement of it which is not obvious, capable of being used or applied in 
trade or industry; and includes an alleged invention;  
“inventor” means the person who actually devises the invention as and includes the legal 
representative of the inventor;  
“licence contract” means a contract or an agreement by which a person grants permission to 
use his or her industrial property rights, know-how, or other technical information or 
technical services;  
“licensee” means a person licensed under a contract which is registered or taken to be 
registered under a relevant law;  
“licensor” means a party to a licence contract who grants the permission under a contract 
registered or taken to be registered under a relevant law; 
“Memorandum of Understanding “ means an agreement between two or more parties that sets 
out certain rights and obligations.  It may not involve direct consideration. 
“Ownership” means the rights holder of genetic materials, research data, IP, technology or 
licence as this may be contained in an agreement or such other document with legal 
force.  Joint ownership is allowed for joint projects. 
“Party/parties” means the persons agreeing to collaborate or in any way involved in an 
agreement of whatever nature such as PIC, MAT, MTA, Assignment and License. 
“Person” means a natural person or an organisation or institution where registered or not. 
“R & D” means research and development.  This could be either primary research or applied 
research or further research aimed at improving a given IP to make it more marketable. 
“Technovation” means developing new ideas, products, services, and processes which exploit 
technology.  At its best, technovation is said to create valuable products and services 
no one has yet asked for or creates "disruptive" change (major leaps in the way things 
are done).  Most of these technovations are in the ICT sector.  Many people are 
developing Apps for different things such as monitoring contacts of COVID-19 positive 
persons, baking using given recipes, identifying theft in supermarkets and others.  
 “Utility model” means any form, configuration or disposition of element of some appliance, 
utensil, tool, electrical and electronic circuitry, instrument, handicraft mechanism or 
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other object or any part of the same allowing a better or different functioning, use, or 
manufacture of the subject matter or that gives some utility, advantage, environmental 
benefit, saving or technical effect not available in a named country before and includes 
micro-organisms or other self-replicable material, products of genetic resources, herbal 
as well as nutritional formulations which give new effects. 
 
Context: Why is this important? 
 SGCs fund research through public money/taxes 
 These grants/projects generate findings that may have IP/IP assets 
 Some of the IP assets so generated may have proprietary value – now or in the future 
 Revenue from the commercialization could be re-invested into research and grow the 
R&D kitty 
 While this requires a policy framework, in many countries this doesn’t already exist 
 Collaborative research/projects require that benefits from such research/innovation 
projects are accessed and/or shared by partners 
 There have been cases where partners have quarrelled and disagreed ; some grown and 
build new relations/enterprises with other funders/networks or some investors have 
taken advantage of the policy vacuum to exploit IP without due 
recognition/acknowledgement or compensation to the IP owners.  
 
4. How to develop an IP strategy: 
Introduction 
It is recognized that science granting councils (SGCs) are funded from public funds.  
SGCs then pass on these funds to research and academic institutions or individuals, either 
competitively or otherwise.  The law relating to SGCs takes three main forms, differing 
from country to country.  In the first form, the law allows SGCs to own IP.  This is the case 
with SGCs in Kenya and Uganda.  For instance in Uganda, the Uganda National Council 
of Science and Technology law 1 has assigned the functions of protecting IP, clearance for 
information on science and technology, disbursement of research funds and transfer of 
                                                             
1 Uganda National Council of Science & Technology Act Cap 290 of 1990 
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technology to the SGC (the Uganda National Council of Science and Technology).  Bodies 
such as the National Agricultural Research Organisation (NARO) of Uganda can grant 
funds to institutions or person but there is no mention of IP.  In Kenya, 2 the Kenya National 
Innovation Agency has the mandate to acquire rights in any technical innovation supported 
by the Agency or to assign such rights, and to facilitate the grant or revocation of any IP.  
There are several research institutions recognized under this law.3  
This means any IP resulting from research funded by SGCs in these countries 
belongs to the SGCs.  SGCs in such countries must work out mechanisms for ownership, 
licensing, assignment and benefit-sharing with other actors.  This form of regulation existed 
in USA before the Bayle-Dole amendment of 1980.  The experience from the USA is that 
this form of regulation stifled the development of IP and commercialization.  The main 
argument here is that since SGCs are funded by government and are therefore already 
guaranteed budgetary allocation from the Treasury, they lack the motivation to 
commercialize IP.  In fact, in the USA, SGCs were granting non-exclusive licences for the 
same IP to many different actors, thereby making it unprofitable to commercialize.  
Universities and research institutions did not have proprietary rights over IPs.  Overall, 
there were too few IPs being registered and far fewer reaching the commercialization state.  
SGCs under this form shall henceforth be referred to as Model I. 
The second form of regulation is where the SGCs fund research and academic 
institutions (including individuals), but the research/academic organisations are allowed to 
own, licence and assign IP.  This is the model currently in operation in the USA after the 
1980 amendment.  Under this model, research institutions and universities are allowed to 
own IP from federally funded projects.  They are also required to share proceeds of 
commercialization with inventors.  They are allowed to give exclusive licences or to assign 
IP.  Universities and research organisations are required to avail information from non-
commercialized IP to other universities and research institutions on reasonable terms.  Most 
importantly, Universities and research institutions are allowed to keep proceeds from 
licences and assignments and to plough it back to research.  Academic and research 
institutions therefore have sufficient motivation for additional funding.  After 1980, in the 
USA, there was an exponential growth in the number of IPs registered and licensed by the 
                                                             
2 Science, Technology and Innovation Act No 28 of 2013 ss 28 & 29 
3 These include: Kenya Medical Research Institute, Kenya Trypanosomiasis Research Institute, Kenya 
Agricultural and Livestock Research Organisation, Kenya Forestry Research Institute, and Kenya Marine & 
Fisheries Institute. 
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research and academic institutions.  SGCs under this form shall henceforth be referred to 
as Model II. 
There is a third form that takes a hybrid of the first two.  In this form of regulation, 
SGCs both fund and also carry out research on their own.  This is well exemplified by the 
Council of Scientific and Industrial Research  (CSIR) set up by the Scientific Research 
Council Act 4 and the South African Medical Research Council (SAMRC).5  CSIR has 
authority to enter into agreements, establish a company, avail technological expertise to 
any person, undertake research and carry out transfer of technology.  SAMRC has similar 
functions.  It is noteworthy, that indeed in South Africa, many Universities have set 
established IP policies and set up IP offices.  In this model, both SGCs and the funded 
institutions are allowed to own, licence and assign IP.  This shall henceforth be referred to 
as Model III. 
The following should be considered when setting up an IP strategy: 
4.1. Consider the nature of your organisation.  
4.2. Establish guidelines for creating intellectual property  
4.3 Analyse your competitive advantage and barriers to entry. ...  
4.4 Analyse third-party interactions. ...  
4.5 Audit your intellectual property. 
4.6 Where to protect your IP 
4.7 Other considerations 
 
4.1. Consider the nature of your organisation.  
Model I SGCs have authority to own, licence and assign IPs generated from their 
funded research.  Such SGCs must put in place agreements with the receiving institutions and 
individuals regarding ownership of IP, Non-disclosure Agreements (NDA), Material transfer 
                                                             
4 No 46 of 1988 (amended by Act No 71 of 1990) 
5 South African Medical Research Council Act No 58 of 1991 
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agreements (MTA), Mutually agreed terms (MAT), guidelines on publications and so on.  
Even where the research or academic institutions source for materials, the manner of benefit-
sharing contemplated in an MTA and or MAT must indicate the pre-eminent position of the 
SGC as the ‘owner’ of all resultant knowledge from the research.  Should academic 
institutions develop their own IP policies, the contents of such policies cannot contradict the 
statute establishing the funding agency. 
Model II SGCs have ‘devolved’ their ownership of IP to research/academic institutions.  
These SGCs should require of research and academic institutions they fund to have a robust IP 
policy in place and make the availability of such policies a condition precedent for funding.  
Under this model, SGCs should provide guidelines on what they want to be contained in the 
policy.  Government recoups their investment through taxation of commercialized IPs.  
Under Model III, SGCs can own, licence and assign IP, in addition to their funding role.  
These SGCs need to put IP policies in place to guide management of IP in their own 
organisations, and to require research/academic institutions to also have reliable IP policies in 
place. 
 
4.2. Establish guidelines for creating intellectual property 
Model I and Model III SGCs as well as the research/academic institutions ought to 
establish guidelines for creating IP.  Such guidelines should cover two main areas.  Firstly, 
guidelines on optimizing searches on patent databases.  In order to register a patent, an inventor 
must disclose details of his or her invention.  Patent databases therefore reflect a repertoire of 
inventions already existing.  Systematic searches of such databases can help avoid duplication 
of effort and waste of public resources.  Registration of a patent blocks any other registration 
of a similar invention.  Coming up with an already patented invention does not do justice to the 
researchers, their institutions or to SGCs.  Such data searches can help in identifying gaps in 
the knowledge where research is needed.  Searches on patent databases save an organisation 
time, effort and resources.  Or worse still, after a lot of investment, it could turn out that the 
organisation cannot enjoy the desired monopoly through registration of IP.  This also means 
that ‘frontline’ staff should be empowered to conduct searches.  This applies with equal force 
to searches on databases of other IPs such as plant varieties and trademarks.  Model II and 
Model III SGCs can require recipients of their funds to have guidelines on patent searches. 
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Secondly, guidelines are needed on IP registration.  Decision making needs to be 
optimized.  A delay to decide on registration of IP could as well mean that someone else comes 
up and registers what the organisation may have been considering working on.  All SGCs must 
have a team of officials dedicated to matters of IP.  Many SGCs focus too much either on 
science and technology or on funding that IP has been neglected.  Many do not have IP offices 
with relevant qualified staff in place.  Research/academic institutions are not fairing any better.  
Our institutions need to make a deliberate move to harness and exploit IP. 
 
4.3 Analyse your competitive advantage  
Some SGCs like the CSIR - and research/academic institutions they fund - are 
focused on technology and the production of utility models and industrial designs.  In the 
process, they may also produce some patentable knowledge.  Others like the South African 
Medical Research Council and its affiliates are keen on medical research.  Model I SGCs like 
Uganda’s National Council of Science and Technology and Kenya’s NACOSTI provide 
funding to research in all fields.  Each SGC needs to analyse and understand its competitive 
advantage.  This helps in channeling resources only to those areas that are close to the 
organisation’s remit.   
Recipients of research funds also need to do likewise.   Recipients such as the  
Uganda National Agricultural Research Organisation and Kenya’s KALRO have a focus on 
agriculture research while the Kenya Marine and Fisheries Research Institute has marine 
resources as its main area of operation.  In the academic arena, Nigeria has over 100 
Universities, South Africa about 25 and Kenya about 70.  All these universities seek funding 
for research.  Almost all of them have duplicate departments, e.g. subjects like History, 
agriculture and Physics are taught at more than 40 of the 70 Universities in Kenya.  The same 
scenario plays itself out at universities in other countries.  It is particularly useful for 
academic institutions to identify their key priorities and focus on IP in those areas.  This 
scenario also portends well for collaborative work so that experts at three to four universities 
can get together to work on one project.   
 
 
4.4 Analyse third-party interactions.  
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Science Granting Councils and receiving institutions need to analyse how they 
interact with thirds parties.  Third parties can include employees, suppliers, contractors, 
customers, partners, and potential infringers.  Your IP policy should clearly define these 
relationships.   
Employees 
Employees can have clauses in their employment contracts on how IP matters relating 
to the organisation are to be handled.  Where an employee is in possession of ‘trade secrets’ 
or has come up with an innovation the manner of ‘benefit-sharing’ must be clear.  An 
organisation will do well to put in place an award scheme for employees to contribute to the 
creation and maintenance of IP.  Key persons involved in IP ought to have enhanced personal 
insurance as they are potential contributors of a lot of revenue to an institution.  
Labour mobility 
Problems tend to arise where researchers are from an institution and funding comes 
from outside.  Or some researchers change institutions while a project is going on.  Matters of 
ownership of genetic resources (where used), IP, access to and transfer of technology ought 
to be addressed as well.  What of a case where research funds are managed by institution A 
and the researcher transfers her services to institution B?  The employee contract should 
always include clauses on how to handle research funds and IP in case of a separation.   
Winding up 
Funding of a research project may involve infrastructure upgrade, purchase of 
equipment such as computers, laboratory equipment, publishing machines, and motor 
vehicles.  Questions arise for example, at the end of a research project which involved 
purchase of motor vehicles – whose vehicles should they be?  There are cases where 
Principal researchers have taken possession of such vehicles, computers have been shared 
and questions of further use of upgraded facilities go unanswered.  All this must be clearly 
addressed in a constituitive agreement, preferably before a project starts.  For  SGCs, this 
should be spelt out in the ‘Letter of Grant’ of research funds.  
Succession planning 
An oft forgotten aspect is one of succession planning.  Employees in an organisation 
will always leave for varied reasons.  It is good for the organisation that work should be able 
to proceed even in the absence of any one or several key persons.  The use of non-disclosure 
agreements (NDA) helps to prevent ‘leakage’ of vital research information.  Any leakage of 
such documents can lead to loss of a competitive advantage.   
Documentation/inventory 
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An organisation ought to preserve very well all documentation protocols.  They come 
in handy where there is need for evidence of having carried out activities towards the 
invention.  Besides, they contain data that can constitute ‘trade secrets’.  
Continuity plan 
Science granting councils should ensure there is a continuity plan in place either in 
their organisations or in the organisations they fund.  To this end, it is necessary to ensure 
sufficient and properly designed agreements relating to development of the research and 
further steps with all collaborators, including visiting scholars/researchers.   
4.5 Audit your intellectual property including an audit of research data. 
The IP policy should make provision for periodic IP audits.  Identify and keep an 
inventory of IPs and potential IPs developed by the organisation. An IP audit should include a 
schedule of registered intellectual property including patents, trademarks, design 
registrations, and plant variety rights.  Also keep a record of unregistered assets such as 
know-how, copyright and even ‘collections’ which can give a competitive advantage.  It is 
important to identify conditions of use such as a license to use intellectual property for 
research purposes only, or a license to be negotiated for commercial purposes.  Also to be 
checked is the scope of protection.   
An IP audit should help to determine 
 gaps in protection, 
 risks, particularly in terms of internal systems, ownership and conditions of use, 
 opportunities as current IP protection may be broader than the current business 
model, and 
 Whether you are spending money on dead wood. 
Many Universities and research institutions churn out a lot of research data annually.  
Some is used for publications while most of it is left to gather dust in libraries.  A regular 
audit of such data could disclose information that can lead to the creation of various IPs.  
Many such institutions do not have an IP office.  In this day and era when income from 
student fees and or the exchequer is continuously shrinking, it is necessary for all such 
institutions to set up and properly staff such offices in order to develop IP as another stream 
of income. 
4.6   Where to protect your IP 
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Different countries have different offices for the protection of IP.  All the countries 
have different registries for various IPs.  For example, there is a registry for copyright; a 
separate one for patents, industrial designs, utility models, and trademarks, geographical 
indications; and a separate registry for plant varieties.  The law considers IPs as private 
property.  So the owner must be proactive.  Enforcement can be achieved through litigation, 
deterrence and registration. 
4.7 Other considerations 
Where an SGC or any of its affiliates is involved in commercialization of IP, other 
considerations come into play.  Competition has the effect of diluting the value of IP.  Where 
research brings out similar information about an invention that is a probable competitor to 
what an organisation already has, it may be advisable not to file any IP protection but instead 
put into the public domain.  One can focus on first mover advantage; build a brand loyalty 
and customer base.  Technical aspects can be protected through patent protection on technical 
aspects key to product base, ability to shut competitors out.  Focus can also be placed on 
Brand Value through trademarks and/or Copyright.    
5. Content of Intellectual Property  
Types of IP include Patents, Copyrights, Trademarks, Service marks, Trade secrets, 
Industrial designs, Geographical indications, and plant varieties. 
Model I & III SGCs – these also own and can licence/assign IP 
These SGCs will be concerned with all IPs.  Most Science Granting Councils tend to 
focus on patents, industrial designs, utility models, trademarks, and computer programmes.  
Although some of these scientists are involved in publications, hardly do they consider the 
‘sale’ of books written by scientists as valuable copyright being ‘commercialized’.  This 
needs to change to accommodate other forms of IP.  Some of these SGCs grant research 
funds to other areas other than the ‘sciences’.  This means, such SGCs should have broader 
policies that accommodate IPs.  Trade secrets permeate mainly research from  
 
Model II SGCs – these do not own IP 
These merely fund research/academic institutions.  They should therefore insist that 
recipients of their funds have policies that cover all IPs. 
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Research institutions 
Most research institutions are specialized.  For example, the CSIR of South Africa 
and related institutions elsewhere, deals with research that can result in patents, utility 
models, industrial designs, trademarks and copyright (for computer programmes).  Uganda’s 
NARO and similar organisations elsewhere focuses on agricultural research.  Here the likely 
IPs are patents, trademarks, trade secrets and new plant varieties.  Research from Kenya’s 
Medical Research Institute and similar institutions is likely to result in patents, trademarks 
and copyright.   
 
Academic institutions 
Academic institutions engage in a very broad range of research cutting across many 
disciplines from the sciences through the arts and cultural studies. These are the institutions 
into have capacity to embrace all forms of IP.  Nevertheless, there is very little cognisance of 
IPs related to music, drama, books and cultural expressions.  Indeed, one area that seems to 
be gradually gaining attention is traditional knowledge- a form of communally owned IP.   
 
 
6. How do I protect my IP? 
Some IP rights arise automatically as soon as the work is created.  These are 
copyright, database rights; design right, rights in passing off, and some rights in confidential 
information.  Rights in patents, utility models, registered trademarks and registered designs 
can only be obtained by application to the Intellectual Property office.  Intellectual property 
rights are national rights; one must ensure that the registrations cover all the countries where 
protection or trade is sought.  Some inventions can be better protected through trade secrets 
which is a cheap and efficient way to do so (like Coca Cola does), but it’s also risky.  Trade 
secrets can also better enjoy protection with the aid of non-disclosure agreements. 
IP can also be protected through registration and defensive publishing.  Defensive 
publishing can also protect against two kinds of actors: those which apply for patents solely 
to collect license fees or damages; and those who patent incremental improvements around 
the core patent to erode its value and take over.   
 
7. How to create and use intellectual property:  
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In order to create and use IP, there must be an IP policy, IP strategy, Relevant 
agreements, Capacity building, an inventory of data/records of IPs, guidelines on third 
party interactions, partnerships and interactions, licensing and assignment, incentives and 
rewards. 
a. An IP policy 
Many institutions in Africa have neither embraced nor benefitted from IP.  In order to 
properly benefit from IP, there is need for each institution to set up an IP policy.  Such policy 
provides for management of IP within an institution, including the office directly concerned 
with IP.  The policy will guide members of an institution on their rights and obligations as 
well as procedures to follow in realizing their IP.  A policy provides for the manner of 
sharing of benefits of commercialization arising from an IP developed from the institution.  
Thus, an IP policy builds confidence in the members regarding their participation in the 
development of IP. 
b. Capacity building 
Capacity building in matters of IP helps to gain support of employees in the 
implementation of an IP policy.  Such employees learn to feel they are appreciated.  These 
employees in turn propagate an institution’s IP policy in collaborating with others. 
c. IP Strategy 
There is need to develop a strategy to create, protect and exploit IP.  Such strategy 
must of necessity include an IP policy already referred to above.  As part of the 
strategy is to map out an institution’s strength so that resources are properly 
channelled.   
d. Inventory of data and records 
Define how the results will be owned, protected and used.  The MoU used to set up a research 
project or other instruments such as the MTA should contain MAT that specify ownership of 
results and how they are to be disseminated and or used.  Keep your scientists’ lab-books and 
log when inventions and designs are made, what they are, and who made them.  Accurate 
record keeping and keenness on records is very important in managing IP.  One can monitor 
use of the data, isolate and keep secrets, determine when data is released for publication and 
when to produce it as evidence in disputes on IP. Keep inventions, designs and ideas secret 
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until you decide to patent or register them (or to keep them secret longer).  It is important not 
to announce results of studies that form the basis of an IP claim beforehand.  An early 
announcement can nullify any claims for IP, especially patents.  Use the grace periods 
available before or during the application process to maintain secrecy.  Secrecy is key, 
especially in relation to patents.  Researchers should avoid rushing to present results of their 
findings at conferences, before a patent is registered. Register relevant domain names.  
Domain names that relate to a business need to be registered.  Identify trade secrets that are 
so valuable that you never disclose them, even under confidentiality obligations A non-
disclosure agreement or also called a confidentiality agreement can be used to bind staff, 
consultants, business partners and other third parties.  Trade secrets are a powerful way of 
protecting IP, if properly done.  An institution would do well to guard her trade secrets.  
Apply for registered trademarks for new brands.  Where brands have been created – the same 
should be protected through trademarks.  Registering an IP early gives the inventor a head 
start.  The law protects a person’s rights according to priorities.  However, depending on the 
nature of the invention, a delay in registration or non-registration is also a way of protecting 
an invention through ‘trade secrets’.  Trade secrets can guarantee longer protection than other 
forms of IP.  A register of IPs an institution owns helps to guide an institution on when some 
may be due for renewal of subscription, completely lapsing, which other areas to work on IP, 
and to know its areas of strength. 
 
e. Incentives for staff 
Create incentives for staff to create patentable inventions, registrable designs and 
protectable copyright.  Incentives for staff make staff work more.  Such incentives can 
be built in the IP policy. 
f. Partnerships and cooperation 
Partnerships work well where it is necessary to share personnel, facilities and equipment.  
It does happen that some specialists are found in research institution that are not 
available in an academic institution, or that one institution is better equipped for certain 
scientific enquiries than the other.  Identify strategic partners with whom to create IP.  
Such partners could include other institutions, researchers or other people with the 
requisite skills.  One should choose partners that have a broad international reach in 
order to maximize from the commercialization.  Ensure consultants transfer to you the 
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intellectual property they create for you.  Where an institution has hired specific 
consultants for purposes of working on defined projects, IP should be transferred to the 
institution under certain MAT.  Involve the right people at the genesis of IP to prevent a 
lot of heartache later on.  The right people get things done the right way.  Sometimes 
some people are placed in certain offices as a political favour.  Others are placed in the 
wrong positions based on other considerations. 
 
g. Licensing and Transfer 
Licence IP to earn royalties and to gain access to new markets.  IP can be licensed 
exclusively or partially.  An exclusive licence amounts to transfer of IP rights to another 
entity.  A partial licence can be limited to a certain territory.  Cross-licence to others to 
reduce licensing fees.  Cross-licensing is a technique for cutting costs.  This involves seeking 
out partners in whose markets one does not want to venture and who might find venturing in 
your market very expensive.  It is a form of exchange of licences.  Be sure to meet your 
obligations under any agreement in IP.  Diligence is required in fulfilling obligations under 
IP.  There should be a record of all prior identified beneficiaries and a formula for sharing the 
proceeds of commercialization.   
8. Issues in Sponsored Research 
Academics rely on research funding to do what they are good at.  Some organisations like 
the Kenya Innovation office claim copyright for their sponsored projects.  In most 
collaborative research with researchers from the West, they come with ‘Form’ or fixed 
agreements that are difficult to vary.  Some researchers in Africa get overly excited at the 
prospects of being participants in such project that they do not check the IP clauses in the 
agreements.  The institutions they come from could have their own IP policies, which 
largely vest IP rights in the institution.  A conflict is likely to arise where the IP 
requirements of the sponsoring agency is at variance with that of the institution to which 
the researcher belongs.  In case of ‘independent’ contractors – a dispute is likely to arise 
in ownership of IP between him and the sponsor.  There is therefore need for 
comprehensive agreement(s) amongst the actors which should specify among others- 
 A description of  deliverables 
Each party to a sponsored research should know what is expected of them.  For 
example, the sponsor of a research should indicate how disbursement of funds will be done, 
i.e. a lump sum send to the cooperating institution or in instalments.  The researcher should 
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know what she is supposed to do in order to access the funds.  The cooperating institution 
should also have clear guidelines on how it is supposed to act in such an arrangement.  
Similarly, if there are consultants involved, duties, obligations and rights should be specified. 
 Definition of the  scope of the project and payment 
Clearly define the scope of the project.  For example, it is necessary to limit the scope in 
order to guide researchers on the boundaries within which they should operate; should new 
and interesting information emerge, can the project be extended?  In terms of payment, it 
should be very clear who manages the research funds and how they are to be disbursed. 
 Option to Assign or License IP  
Assignment of IP is the legal instrument for transferring, say a patent, from an 
inventor to a business.  It is an agreement in which the inventor, now called the ‘assignor’ 
transfers all or part of their right, title and interest in a patent or patent application to the 
‘assignee’, usually a commercial entity.   
Licensing refers to the act of assigning the ownership of an IP to a third party such 
that to make, use and sell your invention either exclusively or non-exclusively, for an amount 
of pre-decided royalties. 
Whether one assigns all or part of their right will be determined by commercial 
considerations. 
 Restrictions in the use of genetic resources or technology that has IP 
Where there are restrictions in the use of genetic resources as expressed either in a PIC or 
MTA, then should a need arise for other uses, the processes of PIC and MTA have to be 
redone. 
 Ownership of IP 
This needs to be agreed upon beforehand.  Sometimes scientists, especially from the West 
engage in acts that are described as ‘biopiracy’.  They get genetic materials based on 
traditional knowledge and patent inventions therefrom without any reference to the local 
communities.  Such patents can be revoked.  In the case of a patent registered by a Dutch 
company in respect of Teff, a cereal that Ethiopians have used for centuries as food and 
which, unlike wheat and rye does not contain glutamine, the agreement for the transfer of 
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materials was not clear on ownership of IP.  However, the patent registered was eventually 
revoked in the Netherlands.  But it became very expensive for Ethiopia to fight for revocation 
throughout all the EU countries. 
Turmeric Patent 
Turmeric is a tropical plant grown in east India. Turmeric powder has been used for 
centuries in India as a medicine, a food ingredient and a dye.  As medicine, it is used as a 
blood purifier, in treating the common cold, and as an anti-parasitic for many skin infections. 
In 1995, the University of Mississippi medical centre was awarded a patent on turmeric for 
wound healing properties.  The Indian Council for Scientific and Industrial Research (CSIR) 
objected to the patent granted.  Therefore, the USPTO revoked the patent agreeing that the 
use of turmeric was an old art of healing wounds known and used in India.  
Neem Patent 
The neem tree is legendary to India, from its roots to its spreading crown; the Neem 
tree contains a number of potent compounds, notably a chemical named azadirachtin.  It is 
used for medicinal purposes in so many fields. The barks, leaves, flowers, seeds of neem tree 
are used to treat a variety of diseases ranging from leprosy to diabetes, skin disorders and 
ulcers. Neem twigs are used as antiseptic tooth brushes since time immemorial. The patent 
for Neem was first filed by W.R. Grace and the Department of Agriculture, USA in European 
Patent Office as a method of controlling fungi on plants a Neem oil formulation. India, 
through the New Delhi-based Research Foundation for Science, Technology and Ecology 
(RFSTE), in co-operation with the International Federation of Organic Agriculture 
Movements (IFOAM) and Magda Aelvoet, former Green Member of the European 
Parliament (MEP) .filed an opposition to the patent.   India proved that neem seeds were 
known and used for centuries in India, both in curing dermatological diseases in humans and 
in protecting agricultural plants from fungal infections.  The European Patent Office (EPO) 
cancelled the patent.  Also, US patents on Neem-based emulsions and solutions were 
cancelled. 
Basmati patent 
Basmati rice is aromatic rice grown in India and Pakistan for centuries.   It is the 
staple food of people in most parts of Asia, For centuries, the farmers in this region 
developed, nurtured and conserved over a hundred thousand distinct varieties of rice to suit 
different tastes and needs.  In 1997, in its patent application, Ricetec, a US company claimed 
that it had invented certain "novel" Basmati lines and grains "which make possible the 
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production of high quality, higher yielding Basmati rice worldwide."   This patent was 
cancelled.   
 
 ownership of equipment purchased 
The MoU and any other agreements between the funders and the 
institution/researchers should specify ownership of any equipment bought with research 
funds.  It is not uncommon that institutions have experienced difficulties with respect to 
motor vehicles purchased specifically for the project.  It becomes even worse where the 
researchers involved come from different institutions, or even transfer to other institutions. 
 Obligations relating to prior informed consent (PIC), Mutually 
Agreed Terms (MAT), and Material Transfer Agreements (MTA) 
A keen eye must be kept on the above agreements.  This is more so important where 
foreign researchers are involved and who may want to ‘run away’ with intellectual property 
rights. 
 Confidentiality of information 
Scientists normally get excited when they generate new data – especially if it appears 
to be novel.  However, rushing to publish such data either at a conference or in a journal 
would negate any patent application based thereon.  It must be clearly stated how data 
generated from the research is to be handled, especially its dissemination.  There may be need 
to delay publicity around results until a patent application has been approved; there may be 
need to keep certain information confidential for commercial purposes.  Rights to the use of 
research results including data should be specified.  Clarifying use of research data can also 
protect institutions from legal liability as a result of the use of the Material or any results 
obtained.  When and the form publications should take ought to be specified. 
There can be a challenge with collective ownership of information/expertise where 
one proposal is generated by several people and a project is funded.  Sometimes researchers 
disagree on who owns the knowledge in the proposal.  Also some researchers may abandon a 
project after having made a distinctive contribution.  In certain cases, some researchers may 
be initially involved and then their names are deleted from the list of researchers on the final 
proposal.   All these aspects must be clearly set out.  It helps to get the scientists to sign non-
disclosure agreements.  In cases where some are left out – there should be a clear procedure 
for dispute resolution both in the agreement and at institutional level. 
 Funding institutions  
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There are challenges around Funding institutions.  For example, they receive a lot of 
applications but only fund some.  How do you protect the knowledge of those not funded?  
The people reviewing applications for funding are normally specialists in that field.  How can 
the ‘rejected’ applications be protected from ‘plagiarism’?  A Funding institution ought to 
have very clear rules binding it and its reviewers.  Furthermore, there must be a policy of 
non-use of ‘rejected’ applications, and further, there should be a policy of ‘returning’ 
applications not accepted for funding.  However, the researchers themselves must be vigilant 
that their proposals are not ‘stolen’ by other researchers.  It is advisable that a funding 
institution publishes all the topics submitted for research and then those accepted for funding. 
In some cases, a funding institution may give out a call for proposals when it has 
already predetermined whom to fund.  In such a case, they could easily take a proposal from 
one person and pass it onto their preferred candidate.  Once again, a funding institution must 
be as fair and as transparent as possible.  Additionally, those submitting proposals ought to be 
vigilant to prevent theft of their work. 
In the matter of Kukali v Ogola 6 the plaintiff (Kukali) had done and completed her 
Master’s thesis at Maseno University.  The defendant (Ogola) was her friend and enrolled at 
the University of Nairobi for a Masters in the same field.  The defendant borrowed the 
plaintiff’s work to read and seek some ‘guidance’.  Instead, she reproduced it both at proposal 
and final level.  The plaintiff found out and sued both the defendant and the University of 
Nairobi.  The plaintiff asked the court not to allow the defendant to graduate using the 
‘plagiarized’ material.  The University was barred from graduating her using that project. 
In order to avoid reputational risk and loss of confidence in it, a funding body should 
strictly adhere to its own set guidelines with regard to funding research. 
 
 Dispute resolution mechanism.  
Disputes are certainly likely to arise where people contract or agree to do something.  
Even if none of the parties is in the wrong, for example, in the case of Force majeure, the 
rights of the parties must be clearly spelled out.  Consider the case of the Corona virus 
pandemic – many agreements got frustrated without any of the contracting parties being in 
the wrong.  Schools and colleges were closed even when students had paid fees, businesses 
were forced closed although they had valid licences to operate, supply contracts involving 
transportation could not be fulfilled or at least not on time due to curfew or ‘lockdown’ 
                                                             
6 [2010] eKLR (HCt), 
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impositions, and so on.  It is therefore necessary for all collaborating institutions to provide 
for dispute settlement in their agreements.  Such a mechanism should specify in which 
country and using which laws a dispute shall be resolved.  With respect to research related 
contracts, it is advisable to consider alternative methods of dispute resolution in the first place 
such as negotiation, mediation and arbitration.  With respect to arbitration, it should be 
clearly stated how many arbitrators are to be used and which law is to be applied, together 
with the venue for arbitration.  Courts will normally respect such attempts before they 
entertain a complaint. 
9. Management of IP at a Research/Academic Institution 
For a long time, many academic institutions did not bother with IP.  They focused 
on the slogan ‘publish or perish’.  As a result, a lot of material was published which 
besides decorating the CVs of the researchers were left to gather dust in many libraries.  
Researchers in the basic sciences in the West were and get awarded with Nobel Prizes.  In 
the developing world, the state of technology (equipment) is so poor that it is near 
impossible to nurture a dream of a Nobel Prize.  With respect to research institutions, 
funding is usually so low that researchers in these institutions remain relevant by 
collaborating with those from the West who bring along funding.  In this arrangement, 
local researchers more often than not hardly bother with IP issues.  In some instances, 
these researchers are only ‘used’ to validate what has been found elsewhere.  This is the 
more so true in clinical trials and biotechnology research in agriculture.   
However, a major contributory factor to the low regard for IP in Africa is lack of 
information or awareness.  The awareness of IP is so low so that IP is hardly a criteria for 
promotion in our academic and research institutions.  Nevertheless, the idea of IP is 
slowly catching up in many research and academic institutions in Africa.  Many have 
woken up to the potential financial outcome of commercializing IP.  Many institutions are 
interested in pursuing this line but they do not know how.   
There are three major steps that ought to be taken.  Firstly, an institution should 
set up an IP policy to guide all matters of IP.  Secondly, all members of the institution 
must be sensitized to the IP Policy.  In fact, the draft IP policy should be given to 
members of the organisation to brainstorm on it as a way of sensitization and increasing 
awareness, aside from providing an opportunity for ownership.  Thirdly, an institution 
should set up an IP office to manage all forms of IP (see Schedule I) 
Research and academic institutions generate a lot of knowledge some of which 
could qualify for protection as intellectual property.  The flip side of this is that most such 
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institutions do not have offices for intellectual property.  The few that have set up such 
offices have challenges with staffing – ranging from budgetary constraints to lack of 
appreciation of which skills to hire for such offices. 
The skills to be hired should be dependent on the functions of such an office (see 
Schedule I).  The functions include – 
(i) Receiving materials for consideration for IP registration such as books, 
research results, new plant varieties, computer programmes, and designs; 
(ii) Preparing/Processing PIC, MTA, MAT, MoU, NDA and other agreements; 
(iii)Sensitization of IP in the institution; 
(iv) Registration, Assignment and licensing of IP; 
(v) Commercialization of IP; and 
(vi) Administration of benefit-sharing agreements 
Clearly, function (i) requires multiple skills such as scientists, computer experts, and 
agriculturalists.  These can be too many to hire.  However, an institution can make use of 
specialised ad hoc committees for various fields to achieve the desired end.  Functions (ii)-
(vi) would require lawyers who are specialized in intellectual property rights law.  However, 
function (v) could also require marketing skills.  If an institution is well resourced, it could 
assign at one person with requisite expertise per function.  Add on one or two administrators 
and the office of intellectual property will be up and functional. 
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SCHEDULE I 
MANAGEMENT OF IP AT A RESEARCH/ACADEMIC INSTITUTION 
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